Convalescent plasma therapy involves the transfusion of plasma collected from a donor who has recovered from Covid-19 to a patient with an active infection. Two recent studies have shown that convalescent plasma therapy can be used in treating critically-ill COVID-19 patients. Penn’s recently launched two-part study will investigate how convalescent plasma therapy works in moderately and severely ill patients. We are talking to Principal Investigator of the study Dr. Katharine J. Bar to understand the nuances of the study.

This talk has been created by CureTalks.com, in association with the University of Pennsylvania to facilitate discussions for solutions, with a mission to heal the world through information and sharing of knowledge. At CureTalks we discuss groundbreaking medical research including a wide range of medical, health, and wellness issues, bringing together the doctors, researchers, and patients on the same platform.

#covid19 #coronavirus #covidtreatment #convalescentplasma

SUBSCRIBE!
https://www.youtube.com/c/CureTalks?sub_confirmation=1

LET'S CONNECT!
Website: https: https://www.curetalks.com/
Facebook: https://www.facebook.com/CureTalks
Instagram: https://www.instagram.com/cure_talks_tx/
Linkedin: https://www.linkedin.com/company/curetalks/?viewAsMember=true
Twitter : https://twitter.com/curetalks
Pinterest: https://in.pinterest.com/trialxcuretalks/_saved/